Title: To Study the Incidence of Acute Kidney Injury in Patients of COVID-19 Disease admitted in a Tertiary Care Hospital

Authors: Dr Anand Kumar Singh, Dr Mukesh Kumar Maurya, Dr Rohit Baiswar, Dr Pratyush Kumar

 DOI: https://dx.doi.org/10.18535/jmscr/v8i12.02

Abstract

Background: In COVID-19 disease, acute respiratory failure and diffuse alveolar damage are common clinical features. Early Symptom include fever, cough and Shortness of breath. Although lungs are the primary organ to be affected by COVID-19, in severe cases other organs can also be affected. Patients admitted with COVID-19, may also have acute kidney damage, some requiring hemodialysis.

Objectives: To study the incidence of AKI in patients of COVID 19 disease.

Methods: An observational study was conducted on 310 patients of COVID 19 disease admitted in a tertiary care hospital.

Results: Out of 310 COVID 19 patients, 227 (73.2%) were males and 83 (26.7%) were females. 81 (26.12 %) patients belong to mild, 75 (24.19%) to moderate and 154 (37.4 %) to severe COVID 19 disease. Overall AKI was present in 75 (24.19%) patients. In mild disease 8 (9.8%) patients, in moderate disease 14 (18.6%) patients and in severe disease 53 (34.4%) patients had AKI. Out of 227 male COVID 19 patients, 48 (21.14%) had mild disease, 63 (27.75%) had moderate disease and 116 (51.10%) had severe COVID 19 disease. AKI was present in 6 (12.5%), 12 (19.04%) and 40 (34.48%) patients of mild, moderate and severe male COVID 19 disease patients respectively. Out of 83 female COVID 19 patients, 33 (39.75%) had mild disease, 12 (14.45%) had moderate disease and 38 (4578. %) had severe COVID 19 disease. AKI was present in 2 (6.06%), 12 (16.66%) and 40 (34.21%) patients of mild, moderate and severe female COVID 19 disease patients respectively.

Keywords: COVID-19, Acute Kidney Injury.

References

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus infected pneumonia. N Engl J Med. 2020; 382:1199-207. doi: 10.1056/NEJMoa2001316.
  2. Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Medrxiv. 2020. doi: 10.1101/2020.02.10.20021675.
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.doi: 10.1016/S0140-6736(20)30183-5.
  4. Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-nCoV) Coronavirus. Am J Respir Crit Care Med. 2020;201(4):P7-P8. doi: 10.1164/rccm.2014P7.
  5. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi: 10.1016/j. jaut.2020.102433.
  6. Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. . Kidney Int. 2020;97:824-8. doi: 10.1016/j. kint.2020.03.001.
  7. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020 Mar 4. doi: 10.1007/ s11606-020-05762-w.
  8. Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):203-208. doi: 10.3760/cma.j.is sn.1001-0939.2020.03.013.
  9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211.
  10. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb7. doi: 10.1001/jama.2020.1585.
  11. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020. doi:10.1056/NEJMoa2002032.
  12. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005;79:884-95. doi: 10.1128/ JVI.79.2.884-895.2005.
  13. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging Coronavirus 2019-nCoV Pneumonia. Radiology. 2020; 295(1):210-217. doi: 10.1148/radiol.2020200274.
  14. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179–84.
  15. Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083-99.
  16. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11(8):875-9. doi: 10.1038/nm1267.
  17. Zou X. Chen Ke, Zou J, Han P, Hao j, Han Z. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front Med. 2020 Mar 12. doi: 10.1007/s11684-020-0754-0.
  18. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol. 2006;17(11): 3067-75. doi: 10.1681/ASN.2006050423.
  19. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12;8.
  20. The Kidney Disease Improving Global Outcomes (KDIGO) Working Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012;2(1):1-138.
  21. IMAI District Clinician Manual. Hospital care for adolescents and adults. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/77751/9789241548290_Vol2_eng.pdf?sequence=3).
  22. Pocket book of hospital care for children: Guidelines for the management of common childhood illnesses: Second edition. Geneva: World Health Organization; 2013 (https://www.who.int/maternal_child_adolescent/documents/child_hospital_care/en/).
  23. Hirsch, J. S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98, 209–218(2020).
  24. Argenziano, M. G. et al. Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series. BMJ https://doi.org/10.1101/2020.04.20.20072116 (2020).
  25. Pei, G. et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. Am. Soc. Nephrol. 31, 1157–1165 (2020).

Corresponding Author

Dr Mukesh Kumar Maurya

Assistant Professor, Department of General Medicine, M.I.M.S. Barabanki, India